| Literature DB >> 30705495 |
Ryan T Conners1, Jennifer L Caputo2, John M Coons2, Dana K Fuller2, Don W Morgan2.
Abstract
IN BRIEF A large number of adults with type 2 diabetes experience comorbidities that discourage physical activity and hinder regular participation in land-based exercise programs. An aquatic exercise program is an innovative exercise modality that incorporates combined aerobic and resistance exercise. The purpose of this study was to determine if an underwater treadmill walking program featuring gradual and progressive increases in walking speed and duration has a positive effect on glycemic control, metabolic health, cardiovascular function, body composition, and leg strength in middle-aged adults with type 2 diabetes.Entities:
Year: 2019 PMID: 30705495 PMCID: PMC6336125 DOI: 10.2337/cd17-0066
Source DB: PubMed Journal: Clin Diabetes ISSN: 0891-8929
Walking Duration and Intensity During the UTT Program
| W1 | W2 | W3 | W4 | W5 | W6 | W7 | W8 | W9 | W10 | W11 | W12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intensity (% HRR) | 40–50 | 40–50 | 40–50 | 50–60 | 50–60 | 50–60 | 50–60 | 50–60 | 50–60 | 50–70 | 50–70 | 50–70 |
| Duration (min) | 10 | 10 | 12 | 12 | 14 | 14 | 16 | 16 | 18 | 18 | 20 | 20 |
| Total time (min) | 30 | 30 | 36 | 36 | 42 | 42 | 48 | 48 | 54 | 54 | 60 | 60 |
Each session included three walking sessions. W, week; % HRR, percentage of heart rate reserve.
Participant Baseline Characteristics
| Mean ± SD | ||
|---|---|---|
| Age (years) | 58.0 ± 5.0 | |
| Sex (F/M) | 16/10 | |
| Height (m) | 1.8 ± 0.2 | |
| Body mass (kg) | 91.2 ± 9.6 | |
| Time since diabetes diagnosis (years) | 7.1 ± 4.6 | |
| Number of current smokers | 3 | |
| Percent taking diabetes medication | 70.4 ± 4.0 | |
| Metformin users | 15 | |
| Metformin dosage (mg/day) | 1127 ± 280 | |
| Sitagliptin users | 3 | |
| Sitagliptin dosage (mg/day) | 92 ± 14 | |
| Participants who reduced medication use during the study | 2 |
Descriptive Statistics for Primary Health Outcomes
| UTT Group ( | Control Group ( | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline Mean | Change Mean | 95% CI for Change Mean | Baseline Mean | Change Mean | 95% CI for Change Mean | |||
| Glycemic control (A1C, %) | 7.25 | –0.91 | –0.43 | 7.90 | 0.02 | –0.03 | 0.07 | |
| Blood lipid profile | ||||||||
| HDL (mg/dL) | 57.23 | 1.20 | 11.11 | 43.38 | –1.46 | –3.07 | 0.15 | |
| LDL (mg/dL) | 101.77 | –1.15 | –10.21 | 7.90 | 133.15 | 2.77 | –2.32 | 7.86 |
| TG (mg/dL) | 163.69 | –11.62 | –28.67 | 5.44 | 215.15 | 0.69 | –4.69 | 6.08 |
| TG/HDL | 4.02 | –1.06 | –2.18 | 0.05 | 5.69 | 0.06 | –0.31 | 0.43 |
| Cardiovascular function | ||||||||
| RHR (bpm) | 74.00 | –13.00 | –3.00 | 82.00 | 3.00 | –3.00 | 9.00 | |
| RDBP (mmHg) | 82.00 | –8.70 | –3.30 | 81.08 | –0.46 | –3.35 | 2.42 | |
| RSBP (mmHg) | 128.62 | –12.29 | –3.09 | 129.08 | 0.15 | –2.91 | 3.21 | |
| 6MWFD (m) | 476.46 | 64.18 | 125.98 | 508.92 | 0.77 | –6.60 | 8.14 | |
| Body composition | ||||||||
| Body mass (kg) | 94.96 | –3.50 | –2.48 | 102.70 | 0.01 | 1.44 | ||
| Body fat (%) | 31.24 | –2.94 | –2.02 | 29.64 | 0.38 | –0.14 | 0.90 | |
| Waist circumference (cm) | 104.89 | –5.10 | –3.21 | 115.54 | 0.80 | –0.04 | 1.64 | |
| Leg strength (ft-lbs) | ||||||||
| Hamstring peak torque @ 30° · second–1 | 73.80 | 2.46 | 10.77 | 87.37 | –0.51 | –2.91 | 1.89 | |
| Hamstring peak torque @ 60° · second–1 | 52.87 | 1.75 | 14.22 | 64.38 | 0.50 | –0.69 | 1.68 | |
| Quadriceps peak torque @ 30° · second–1 | 70.00 | 3.51 | –0.06 | 7.08 | 85.40 | 0.07 | –1.41 | 1.55 |
| Quadriceps peak torque @ 60° · second–1 | 50.70 | 3.07 | 12.59 | 60.51 | 0.03 | 1.97 | ||
Boldface indicates changes having a 95% CI that excludes 0.